Literature DB >> 11245414

The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.

S A Ahmad1, W Liu, Y D Jung, F Fan, M Wilson, N Reinmuth, R M Shaheen, C D Bucana, L M Ellis.   

Abstract

Angiopoietin (Ang) 1 and Ang-2 are important regulators of endothelial cell survival. Current models suggest that an increase in Ang-2 expression in endothelial cells leads to initiation of angiogenesis. We stably transfected HT29 colon cancer cells with cDNA constructs for Ang-1 or -2 or with vector alone, injected the cells s.c. into nude mice, and assessed tumor growth. Immunohistochemical analyses confirmed sustained increases of Ang-1 and -2 in the tumors. The tumors produced by the Ang-2-transfected cells were larger than the tumors produced in the other groups; those tumors also had higher vessel counts and proliferative indices than tumors in the other groups. Tumors produced by the Ang-1 transfectants had fewer vessels and lower tumor cell proliferative indices than tumors in the other groups. These data suggest that imbalances between Ang-1 and -2 that result in a net gain of Ang-2 activity lead to enhanced tumor angiogenesis and growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245414

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  Understanding and targeting resistance to anti-angiogenic therapies.

Authors:  Jeffrey M Clarke; Herbert I Hurwitz
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 2.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

3.  Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.

Authors:  Kelly E Johnson; Jodi A Forward; Mason D Tippy; Julia R Ceglowski; Saleh El-Husayni; Rajesh Kulenthirarajan; Kellie R Machlus; Erica L Mayer; Joseph E Italiano; Elisabeth M Battinelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

4.  Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer.

Authors:  Jun Wang; Kai-Chun Wu; De-Xin Zhang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 5.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

6.  Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.

Authors:  Ping Guo; Yorihisa Imanishi; Frank C Cackowski; Michael J Jarzynka; Huo-Quan Tao; Ryo Nishikawa; Takanori Hirose; Bo Hu; Shi-Yuan Cheng
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.

Authors:  Bo Hu; Ping Guo; Quan Fang; Huo-Quan Tao; Degui Wang; Motoo Nagane; Hui-Jein Su Huang; Yuji Gunji; Ryo Nishikawa; Kari Alitalo; Webster K Cavenee; Shi-Yuan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

8.  Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Kyu Yun Jang; Myoung Jae Kang; Harry Park; Andrzej S Tarnawski
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

9.  Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer.

Authors:  Hui-Peng Wang; Yang-Yun Wang; Jie Pan; Rong Cen; Yuan-Kun Cai
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Expression and significance of angiopoietin-2 in gastric cancer.

Authors:  Xiao-Dong Sun; Xing-E Liu; Jin-Min Wu; Xiu-Jun Cai; Yi-Ping Mou; Jun-Da Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.